Waverley Pharma Competitors and Similar CompaniesClear all
Waverley Pharma's competitors and similar companies include Progenics Pharmaceuticals.
 Waverley Pharma Waverley Pharma is a specialty pharma company developing and commercializing therapeutics that aim to cure generic oncology. |  Progenics Pharmaceuticals Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients. | |
Founding Date | Founding Date 2014 | Founding Date 1986 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Winnipeg, CA HQ | Locations New York, US HQ Billerica, US |
Employees | Employees N/A | Employees 49 |
Financial | ||
Revenue (est.) | Revenue (est.) $1.3m (FY, 2025) | Revenue (est.) $35m (FY, 2019) |
Cost of goods | Cost of goods $752k (FY, 2025) | Cost of goods $3.2m (FY, 2019) |
Gross profit | Gross profit $597k (FY, 2025) | Gross profit $31.8m (FY, 2019) |
Net income | Net income ($499k) (FY, 2025) | Net income ($68.6m) (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Progenics Pharmaceuticals
HQ
New York, US
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
View company